These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 18794346)
1. Tuberous sclerosis complex proteins control axon formation. Choi YJ; Di Nardo A; Kramvis I; Meikle L; Kwiatkowski DJ; Sahin M; He X Genes Dev; 2008 Sep; 22(18):2485-95. PubMed ID: 18794346 [TBL] [Abstract][Full Text] [Related]
2. The Tsc1-Tsc2 complex influences neuronal polarity by modulating TORC1 activity and SAD levels. Wildonger J; Jan LY; Jan YN Genes Dev; 2008 Sep; 22(18):2447-53. PubMed ID: 18794342 [TBL] [Abstract][Full Text] [Related]
4. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901 [TBL] [Abstract][Full Text] [Related]
5. The role of TSC1 and TSC2 proteins in neuronal axons. Karalis V; Wood D; Teaney NA; Sahin M Mol Psychiatry; 2024 Apr; 29(4):1165-1178. PubMed ID: 38212374 [TBL] [Abstract][Full Text] [Related]
6. The tuberous sclerosis complex. Orlova KA; Crino PB Ann N Y Acad Sci; 2010 Jan; 1184():87-105. PubMed ID: 20146692 [TBL] [Abstract][Full Text] [Related]
7. Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes. Miyazaki M; McCarthy JJ; Esser KA FEBS J; 2010 May; 277(9):2180-91. PubMed ID: 20412061 [TBL] [Abstract][Full Text] [Related]
8. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259 [TBL] [Abstract][Full Text] [Related]
9. Tuberous sclerosis as an underlying basis for infantile spasm. Yeung RS Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899 [TBL] [Abstract][Full Text] [Related]
10. The association of neurodevelopmental abnormalities, congenital heart and renal defects in a tuberous sclerosis complex patient cohort. Robinson J; Uzun O; Loh NR; Harris IR; Woolley TE; Harwood AJ; Gardner JF; Syed YA BMC Med; 2022 Apr; 20(1):123. PubMed ID: 35440050 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760 [TBL] [Abstract][Full Text] [Related]
12. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Dabora SL; Jozwiak S; Franz DN; Roberts PS; Nieto A; Chung J; Choy YS; Reeve MP; Thiele E; Egelhoff JC; Kasprzyk-Obara J; Domanska-Pakiela D; Kwiatkowski DJ Am J Hum Genet; 2001 Jan; 68(1):64-80. PubMed ID: 11112665 [TBL] [Abstract][Full Text] [Related]
14. Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events. Qin W; Chan JA; Vinters HV; Mathern GW; Franz DN; Taillon BE; Bouffard P; Kwiatkowski DJ Brain Pathol; 2010 Nov; 20(6):1096-105. PubMed ID: 20633017 [TBL] [Abstract][Full Text] [Related]
15. Identification of regions critical for the integrity of the TSC1-TSC2-TBC1D7 complex. Santiago Lima AJ; Hoogeveen-Westerveld M; Nakashima A; Maat-Kievit A; van den Ouweland A; Halley D; Kikkawa U; Nellist M PLoS One; 2014; 9(4):e93940. PubMed ID: 24714658 [TBL] [Abstract][Full Text] [Related]
16. Biallelic Mutations in Winden KD; Sundberg M; Yang C; Wafa SMA; Dwyer S; Chen PF; Buttermore ED; Sahin M J Neurosci; 2019 Nov; 39(47):9294-9305. PubMed ID: 31591157 [TBL] [Abstract][Full Text] [Related]
17. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia. Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400 [TBL] [Abstract][Full Text] [Related]
18. Tuberous Sclerosis Complex (TSC) Inactivation Increases Neuronal Network Activity by Enhancing Ca Hisatsune C; Shimada T; Miyamoto A; Lee A; Yamagata K J Neurosci; 2021 Sep; 41(39):8134-8149. PubMed ID: 34417327 [TBL] [Abstract][Full Text] [Related]
19. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481 [TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors. Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]